Top Tech Companies (2,070)
Don't see your company?
Create a company profile
Empire Genomics is a leader in the field of molecular diagnostic services for oncology diseases.
Hyalose LLC is a biotechnology company focused on the commercialization of unique recombinant technologies for producing Hyaluronic Acid .
Gene by Gene offers a wide range of affordable genetic testing lab services using cutting-edge biotechnology, giving unparalleled insight into ourselves and our future.
Opexa Therapeutics develops patient-specific immunotherapies for the treatment of multiple sclerosis.
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids* , as well as clinical programs in multiple therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. Review our Community Guidelines: https://bit.ly/3L8M8hx *in collaboration with AbbVie
.png)
OnePointOne is a mission-driven technology company founded on the reality that 1.1 billion people began this millennium hungry. To solve this problem, OnePointOne developed a fully automated vertical farming system to improve the health of humanity through plant-based foods and medicines. Using a patented aeroponic system, OnePointOne is able to quickly and sustainably grow the chemical-free, nutrient rich foods and revolutionary biopharmaceuticals needed to solve some of the world’s biggest challenges.
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP, P450, AChE and BChE Activity among others.
As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside. VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability. Our “white-glove” customer care is supported by a PhD-level team with decades of collective experience to devise the best gene delivery solutions for our customers. As a result, we have received glowing customer testimonials and numerous citations in high-impact publications. Operating as a multinational company with branches in North America, Europe, China, Japan, South Korea, Australia and Israel, VectorBuilder has served over 50,000 customers from several thousand organization worldwide, including universities, research institutions, biotech/pharma companies, and governmental agencies. So we ask you one question: Will you join us in the gene delivery revolution？
MiMedx is a biopharmaceutical company.
AnaBios provides contract research services for biotechnology and pharmaceutical industries.
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Synexus is a company dedicated to conducting clinical studies.
OneOme, co-founded by Mayo Clinic, is working to help providers incorporate pharmacogenomics into patient care by offering the RightMed Test and associated tools. T
Bragg Peak Systems designs and manufactures medical and particle therapy planning and management systems.
Selleck provides signaling inhibitors, modulators and compound libraries with terrific validation, customer reviews, product citations, tech support and prompt delivery.
SpIntellx is a computational pathology company developing novel AI tools based on spatial analytics.
Impact Proteomics makes all inclusive kits for protein, peptide, and proteome sample preparation and clean up.
Welcome to the new era of skin cancer detection. At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible. The DermTech Smart Sticker collects an RNA sample by painlessly lifting skin cells off the entire surface of a mole. This gives doctors the power to diagnose skin cancer in its earliest stages—without a scalpel, without cutting, without scarring. After collection, stickers are sent to our team of scientists in the Gene Lab, the only commercial lab to extract nucleic acids and other proteins from non-invasive skin samples. We amplify RNA molecules to detect two specific genes that are highly predictive of melanoma—PRAME and LINC00518. This process provides 10,000x greater precision in the ability to detect melanoma. We have created the step before the scalpel—a tool doctors have never had before. Now the doctor has the choice of using a non-invasive, highly accurate test to check for melanoma without cutting. And this is just the beginning. We are developing other tests using the Smart Sticker that will further advance early disease detection. Help us change the world of dermatology. Together let’s diagnose skin cancer early and make melanoma a disease of the past.
Today only 1 out if 4 cancer drugs prolongs life because we treat all the patients the same way. Genomic Expression’s OneRNA™ test can save lives and make healthcare delivery more effective by sequencing RNA and linking RNA’s to approved therapies and clinical trials.
Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.
